CardioWash: Cardiovascular diagnostic test in a mouthwashMolecular testing for cardiovascular genetic risk factors is now available in a mouthwash
Cardiovascular disease is the number one killer of both men and women in the United States.
The Centers for Disease Control and Prevention (CDC) reports that 1 in 3 Americans have cardiovascular disease and that approximately 735,000 Americans will suffer a heart attack each year.
It is time to take a more preventative approach to cardiovascular disease!
Stone Clinical Laboratories is pleased to announce its newest test offering: CardioWash™.
CardioWash™ is a state-of-the-art molecular diagnostic test that focuses on risk stratification of cardiovascular disease using a non-invasive oral rinse. CardioWash™ will help identify genetic risk factors associated with cardiovascular disease, as well as provide information that can affect a patient’s response to many commonly-prescribed cardiovascular medications.Each easy-to-read CardioWash™ report will provide information that will assist the patient and provider in taking steps necessary to promote optimal cardiovascular health.
Cardiovascular genetic testing is now in a mouthwash!
Stone Clinical Laboratory has created an innovative simple-to-use mouthwash genetic testing platform that is non-invasive, accurate, and potentially life-saving.